Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/27/2022* -- Results Q3 2022 -- 4.82 --
10/27/2022* 08:30 EST Earnings Call Q3 2022 -- -- --
07/28/2022 08:30 EST Earnings Call Q2 2022 -- -- --
07/28/2022 -- Results Q2 2022 5.51 4.98 10.61%
04/28/2022 -- Results Q1 2022 7.25 6.21 16.80%
04/28/2022 08:30 EST Earnings Call Q1 2022 -- -- --
02/02/2022 -- Results Q4 2021 6.54 5.27 24.01%
02/02/2022 08:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/27/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/28/2022
Beat/Miss Upgrade
Return Since -8.55%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).
URL https://corporate.thermofisher.com
Investor Relations URL https://ir.thermofisher.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Large Cap/Blend
Next Earnings Release Oct. 27, 2022 (est.)
Last Earnings Release Jul. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 14, 2022

Dividends

Dividend Per Share (TTM) 1.12
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.1446
Yield to Sector 0.1151
Yield to Industry 0.5354
Last Dividend Amt. 0.30
Dividend Frequency Quarterly
Last Ex-Dividend Date Sep. 14, 2022
Yield (TTM) 0.21%
Forward Yield 0.22%
Payout Ratio 5.71%
Cash Payout Ratio 6.71%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
13.75%
-0.12%
35.03%
18.21%
45.55%
43.71%
43.54%
-17.99%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.66%
12.11%
-42.90%
-14.05%
-74.84%
-73.81%
21.72%
-21.18%
-63.93%
--
--
--
--
--
-48.03%
-11.89%
-75.58%
--
--
--
--
--
--
-73.76%
-70.89%
--
--
--
--
--
--
-14.18%
-69.64%
As of October 05, 2022.

Profile

Edit
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).
URL https://corporate.thermofisher.com
Investor Relations URL https://ir.thermofisher.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Large Cap/Blend
Next Earnings Release Oct. 27, 2022 (est.)
Last Earnings Release Jul. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 14, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
IHI 1.039B USD 17.66%
FSMEX 1.197B USD 15.74%
XLV 1.661B USD 4.44%
VHT 724.82M USD 3.90%
PACLX 1.341B USD 2.94%
CAFFX 1.537B USD 2.34%
VPMCX 1.247B USD 2.08%
CGFFX 2.789B USD 1.38%
IVW 374.47M USD 1.37%
VIGRX 1.749B USD 1.20%
VUG 1.749B USD 1.20%
IWD 512.31M USD 1.05%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter TMO Tweets